Koyfin Home > Directory > Health Care > Amgen Inc > Cash Flow from Operations

Amgen Inc Cash Flow from Operations Chart (AMGN)

Amgen Inc annual/quarterly Cash Flow from Operations from 2010 to 2020. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Amgen Inc Cash Flow from Operations for the quarter ending September 09, 2020 was $3,368m a 25.36% increase of 854m year over year
  • Amgen Inc Cash Flow from Operations for the last 12 months ending September 09, 2020 was $10,858m a 15.73% increase of 1,708m year over year
  • Amgen Inc Annual Cash Flow from Operations for 2019 was $9,150m a -23.45% decrease of -2,146m from 2018
  • Amgen Inc Annual Cash Flow from Operations for 2018 was $11,296m a 1.05% increase of 119m from 2017
  • Amgen Inc Annual Cash Flow from Operations for 2017 was $11,177m a 7.36% increase of 823m from 2016
Other Cash Flow Metrics:
  • Amgen Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $3,068m a 48.86% increase of 1,499m year over year
  • Amgen Inc Total Revenue for the quarter ending December 12, 2018 was $6,230m a 10.85% increase of 676m year over year
View Chart On Koyfin

Quarterly AMGN Cash Flow from Operations Data

09/2020$3,368m
06/2020$2,842m
03/2020$2,134m
12/2019$2,514m
09/2019$3,377m
06/2019$1,414m
03/2019$1,845m
12/2018$3,194m
09/2018$3,273m
06/2018$2,102m

Annual AMGN Cash Flow from Operations Data

2019$9,150m
2018$11,296m
2017$11,177m
2016$10,354m
2015$9,731m
2014$8,952m
2013$6,291m
2012$5,882m
2011$5,119m
2010$5,787m